Business
Polaris International Holdings, Inc. to Release Energy Drink Shot
Polaris International Holdings, Inc. to Release Energy Drink Shot.
About this update from Polaris International Holdings Inc.
[{"type":"text","content":"\n \n \n Polaris International Holdings, Inc. to Release Energy Drink Shot\n \n \nPolaris International Holdings, Inc. to Release Energy Drink Shot\n \n PLANO, TX--(Marketwired - May 28, 2014) - Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce it has reached an agreement with a Dallas based manufacturer to produce a proprietary energy drink shot product as part of its hemp based nutraceutical supplement line. The energy drink shot will be the 3rd nutraceutical product of the Company to go along with its hemp protein powder and brain health supplements. \n Many leading reports forecast sales of energy drinks and shots will grow to a value of $21.5 billion by 2017. The hemp energy line is an up and coming product in the sector and while the sector has much competition, this is area of the sector is not over come with competition. The hemp oil is free from THC and it contains important vitamins and minerals that are essential for a healthy life. It helps the body fight health problems such as obesity, diabetes, high cholesterol and high blood pressure. \n \"Polaris continues to make strides everyday with product development. We feel the products we are producing will make a difference in our customer's health and quality of life,\" states Dr. Avila.\n ABOUT THE COMPANY\n Polaris International Holdings, Inc.'s line ProCannas, focuses on the manufacture and distribution of new, pharmaceutical grade cannabinoid based products for medicinal use. With the Joint Venture 70 acre hemp farm in Kentucky, the Company will grow and develop a large portion of its own hemp products. The Company is also launching a nutraceutical line of products in the Fall of 2014. Laws are expected to become even more favorable for companies like ProCannas. The Company intends to target a broad range of specialties with this novel product, including but not limited to sports medicine, pain management, neurology, and osteopathic medicine.\n Safe Harbor Statement:\n This news release includes forward-looking statements pertaining to future anticipated projected plans, performance and developments, intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Any statements on this news release that are not statements of historical fact should be considered...